News & publications
What Prolong has announced, presented and published.
Key publications
- 2025Expanded access use of Sanguinate: over 100 casesJahr JS, et al. Anesthesia ResearchPaper
- 2024HEMERA-1 Phase 1Linfante I, et al. Stroke: Vascular and Interventional NeurologyPaper
- 2022Canine model of permanent occlusionChristoforidis GA, et al. Journal of NeuroInterventional SurgeryPaper
- 2018Collateral blood flow during stroke in hypertensive ratsCipolla MJ, et al. Journal of Cerebral Blood Flow & MetabolismPaper
- 2017PET imaging in delayed cerebral ischemiaDhar R, et al. Neurocritical CarePaper
Other news
- Apr 30, 2026FDA grants Breakthrough Therapy designation for PP-007 in A-LVO strokeThe designation covers PP-007 in acute ischemic stroke due to anterior large vessel occlusion.News
- Feb 4, 2026HEMERA-1 and the HERMES-24 score at ISC 2026Poster: using 24-hour scores to predict 90-day outcomes in HEMERA-1, toward earlier interim analysis in stroke drug trials.Presentation
- Oct 20, 2025HEMERA-1 final results presented at World Stroke Congress 2025Phase 1/2 results presented in Barcelona.Presentation
- Feb 5, 2025HEMERA-1 data at International Stroke Conference 2025Preliminary Phase 1 data presented at ISC 2025.Presentation
- Nov 13, 2024PP-007 CMC and clinical data at ISBS 2024Manufacturing and clinical data at the International Symposium on Blood Substitutes.Presentation
- Oct 30, 2024FDA grants Fast Track designation for PP-007Fast Track designation granted during the HEMERA-1 study.News
- Apr 23, 2024HEMERA-1 Phase 1 published in Stroke: Vascular and Interventional NeurologyLinfante I, et al. 2024;4(4):e001246.Publication
- Feb 9, 2023HEMERA-1 Phase 1 at ISC 2023 Late-Breaking ScienceFirst HEMERA-1 data, presented in the Late-Breaking Science session.Presentation